Coccidioidomycosis in transplant recipients: A primer for clinicians in nonendemic areas

Current Opinion in Organ Transplantation

Volumn 14, Issue 6, 2009, Pages 606-612

  Vikram, Holenarasipur R ^a   Blair, Janis E ^a  

^a MAYO CLINIC HOSPITAL   (United States)

Author keywords

Coccidioidomycosis; Fungal; Lung diseases; Mycoses; Organ transplantation

Indexed keywords

AMPHOTERICIN B; CD3 ANTIBODY; COCCIDIOIDIN; CORTICOSTEROID; CYCLOSPORIN; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; POSACONAZOLE; PREDNISONE; PYRROLE DERIVATIVE; TACROLIMUS; THYMOCYTE ANTIBODY; VORICONAZOLE;

ACUTE GRAFT REJECTION; ALOPECIA; BIOPSY; BRONCHOSCOPY; COCCIDIOIDOMYCOSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRY SKIN; EARLY DIAGNOSIS; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HYPOXIA; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER FAILURE; LUMBAR PUNCTURE; MICROPHOTOGRAPHY; ORGAN TRANSPLANTATION; PNEUMONIA; REVIEW; SIDE EFFECT; TRAVEL;

ANTIFUNGAL AGENTS; COCCIDIOIDOMYCOSIS; EARLY DIAGNOSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOLOGY; ORGAN TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; TRAVEL; TREATMENT OUTCOME;

EID: 74349131149     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283327d62     Document Type: Review

References (54)

1. Hirschmann JV. The early history of coccidioidomycosis: 1892-1945. Clin Infect Dis 2007; 44:1202-1207.
2. Ampel NM. Coccidioidomycosis: a review of recent advances. Clin Chest Med 2009; 30:241-251.
3. Kirkland TN, Fierer J. Coccidioidomycosis: a reemerging infectious disease. Emerg Infect Dis 1996; 2:192-199.
4. Bissell SR, Weiss EC. Increase in coccidioidomycosis: California, 2000- 2007. MMWR Morb Mortal Wkly Rep 2009; 58:105-109.
5. Galgiani JN. Coccidioidomycosis. West J Med 1993; 159:153-171.
6. Parish JM, Blair JE. Coccidioidomycosis. Mayo Clin Proc 2008; 83:343-348.
7. Chang DC, Anderson S, Wannemuehler K, et al. Testing for coccidioidomycosis among patients with community-acquired pneumonia. Emerg Infect Dis 2008; 14:1053-1059.
8. Kim MM, Blair JE, Carey EJ, et al. Coccidioidal pneumonia, Phoenix, Arizona, USA, 2000-2004. Emerg Infect Dis 2009; 15:397-401.
9. Valdivia L, Nix D, Wright M, et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis 2006; 12:958-962.
10. Spinello IM, Munoz A, Johnson RH. Pulmonary coccidioidomycosis. Semin Respir Crit Care Med 2008; 29:166-173.
11. Louie L, Ng S, Hajjeh R, et al. Influence of host genetics on the severity of coccidioidomycosis. Emerg Infect Dis 1999; 5:672-680.
12. Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis 2005; 41:1217-1223.
13. Blair JE, Coakley B, Santelli AC, et al. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia 2006; 162:317-324.
14. Ampel NM. Coccidioidomycosis in persons infected with HIV-1. Ann N Y Acad Sci 2007; 1111:336-342.
15. Blair JE. State-of-the-art treatment of coccidioidomycosis skeletal infections. Ann N Y Acad Sci 2007; 1111:422-433.
16. Blair JE. State-of-the-art treatment of coccidioidomycosis: skin and soft-tissue infections. Ann N Y Acad Sci 2007; 1111:411-421.
17. Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis 2006; 42:103-107.
18. Mertz LE, Blair JE. Coccidioidomycosis in rheumatology patients: incidence and potential risk factors. Ann N Y Acad Sci 2007; 1111:343-357.
19. Ampel NM, Giblin A, Mourani JP, Galgiani JN. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis. Clin Infect Dis 2009; 48:172-178.
20. Ampel NM. The complex immunology of human coccidioidomycosis. Ann N Y Acad Sci 2007; 1111:245-258.
21. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351:2715-2729.
22. Blair JE, Balan V, Douglas DD, Hentz JG. Incidence and prevalence of coccidioidomycosis in patients with end-stage liver disease. Liver Transpl 2003; 9:843-850.
23. Descamps-Latscha B. The immune system in end-stage renal disease. Curr Opin Nephrol Hypertens 1993; 2:883-891.
24. SachdevMS, Blair JE, Mulligan DC, Kusne S. Coccidioidomycosis masked by symptoms of end-stage liver disease in transplant candidates. Transpl Infect Dis 2007; 9:153-155.
25. Cohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioidomycosis in renal replacement therapy. Arch Intern Med 1982; 142:489-494.
26. Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med 2006; 119:964-969.
27. Dosanjh A, Theodore J, Pappagianis D. Probable false positive coccidioidal serologic results in patients with cystic fibrosis. Pediatr Transplant 1998; 2:313-317.
28. Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 2001; 33:1536-1544.
29. Blair JE, Kusne S, Carey EJ, Heilman RL. The prevention of recrudescent coccidioidomycosis after solid organ transplantation. Transplantation 2007; 83:1182-1187.
30. Blair JE. Coccidioidomycosis in liver transplantation. Liver Transpl 2006; 12:31-39.
31. Holt CD, Winston DJ, Kubak B, et al. Coccidioidomycosis in liver transplant patients. Clin Infect Dis 1997; 24:216-221.
32. Blair JE. Coccidioidomycosis in patients who have undergone transplantation. Ann N Y Acad Sci 2007; 1111:365-376.
33. Blair JE, Douglas DD, Mulligan DC. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transpl Infect Dis 2003; 5:3-8.
34. Braddy CM, Heilman RL, Blair JE. Coccidioidomycosis after renal transplantation in an endemic area. Am J Transplant 2006; 6:340-345.
35. Glenn TJ, Blair JE, Adams RH. Coccidioidomycosis in hematopoietic stem cell transplant recipients. Med Mycol 2005; 43:705-710.
36. Riley DK, Galgiani JN, O'Donnell MR, et al. Coccidioidomycosis in bone marrow transplant recipients. Transplantation 1993; 56:1531-1533.
37. Schriber J, Almond H, Alvarnas J, Sarkadee-Adoo C. Successful allogeneic bone marrow transplantation in a patient with active coccidioidomycosis. Bone Marrow Transplant 2005; 35:927-928.
38. Cha JM, Jung S, Bahng HS, et al. Multiorgan failure caused by reactivated coccidioidomycosis without dissemination in a patient with renal transplantation. Respirology 2000; 5:87-90.
39. Vartivarian SE, Coudron PE, Markowitz SM. Disseminated coccidioidomycosis: unusual manifestations in a cardiac transplantation patient. Am J Med 1987; 83:949-952.
40. Blair JE, Douglas DD. Coccidioidomycosis in liver transplant recipients relocating to an endemic area. Dig Dis Sci 2004; 49:1981-1985.
41. Keckich DW, Vikram HR, Blair JE. Coccidioides fungemia: report of cases from Mayo Clinic Arizona and review of the literature. 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Diseases Society of America 46th Annual Meeting; 25-28 October 2008; Washington, District of Columbia, USA: American Society for Microbiology; 2008. p. 669.
42. Miller MB, Hendren R, Gilligan PH. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol 2004; 42:2347-2349.
43. Tripathy U, Yung GL, Kriett JM, et al. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thorac Surg 2002; 73:306-308.
44. Wright PW, Pappagianis D, Wilson M, et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 2003; 37:1265-1269.
45. Blair JE, Mulligan DC. Coccidioidomycosis in healthy persons evaluated for liver or kidney donation. Transpl Infect Dis 2007; 9:78-82.
46. Assi MA, Binnicker MJ, Wengenack NL, et al. Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: use of polymerase chain reaction. Liver Transpl 2006; 12:1290-1292.
47. Binnicker MJ, Buckwalter SP, Eisberner JJ, et al. Detection of Coccidioides species in clinical specimens by real-time PCR. J Clin Microbiol 2007; 45:173-178.
48. Bruggemann RJ, Alffenaar JW, Blijlevens NM, et al. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. Clin Infect Dis 2009; 48:1441-1458.
49. Anstead GM, Corcoran G, Lewis J, et al. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis 2005; 40:1770-1776.
50. Antony S. Use of the echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient. Clin Infect Dis 2004; 39:879-880.
51. Antony SJ, Jurczyk P, Brumble L. Successful use of combination antifungal therapy in the treatment of coccidioides meningitis. J Natl Med Assoc 2006; 98:940-942.
52. Park DW, Sohn JW, Cheong HJ, et al. Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. BMC Infect Dis 2006; 6:26.
53. Stevens DA, Rendon A, Gaona-Flores V, et al. Posaconazole therapy for chronic refractory coccidioidomycosis. Chest 2007; 132:952-958.
54. Freifeld A, Proia L, Andes D, et al. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother 2009; 53:1648-1651.